Expert Opinion on Drug Metabolism and Toxicology This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Fibroblast growth factor receptor (FGFR) inhibitors in cholangiocarcinoma: current status, insight on resistance mechanisms and toxicity management
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - February 13, 2022 Category: Drugs & Pharmacology Authors: Sakti Chakrabarti Heidi D. Finnes Amit Mahipal Source Type: research

Peripheral neuropathy and headache in cancer patients treated with immunotherapy and immuno-oncology combinations: the MOUSEION-02 study
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - January 25, 2022 Category: Drugs & Pharmacology Authors: Alessandro Rizzo Matteo Santoni Veronica Mollica Francesco Logullo Matteo Rosellini Andrea Marchetti Luca Faloppi Nicola Battelli Francesco Massari Source Type: research

Current status and future outlooks on therapeutic drug monitoring of fluorouracil
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - January 25, 2022 Category: Drugs & Pharmacology Authors: Eduard Schmulenson Nigina Zimmermann Gerd Mikus Markus Joerger Ulrich Jaehde Source Type: research

Potential and real drug interactions in patients treated with abiraterone or enzalutamide in clinical practice
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - January 21, 2022 Category: Drugs & Pharmacology Authors: Juan Vicente-Valor Vicente Escudero-Vilaplana Roberto Collado-Borrell Sara P érez-Ramírez Cristina Villanueva-Bueno Álvaro Narrillos-Moraza Sebasti án García-Sánchez Manel Beamud-Cort és Ana Herranz Mar ía Sanjurjo Source Type: research

Current status and future perspectives on the use of therapeutic drug monitoring of thiopurine metabolites in patients with inflammatory bowel disease
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - January 20, 2022 Category: Drugs & Pharmacology Authors: Debbie S. Deben Dennis R. Wong Adriaan A. van Bodegraven Source Type: research

Evaluating the risk of toxicity and adverse drug interactions involving recreational GHB use and prescribed drugs
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - January 20, 2022 Category: Drugs & Pharmacology Authors: Giovanna Ricci Francesco Paolo Busard ò Filippo Gibelli Ascanio Sirignano Pietro Brunetti Source Type: research

An evaluation of the pharmacokinetics of inclisiran in the treatment of atherosclerotic cardiovascular disease
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - January 20, 2022 Category: Drugs & Pharmacology Authors: Brian Tomlinson Elaine Chow Paul Chan Christopher Wai Kei Lam Source Type: research